HAMPTON, N.H. -- Fisher Scientific International Inc. (NYSE: FSH) today announced that it has received the required consents from note holders to execute supplemental indentures amending the indentures relating to its: --6 3/4 percent Senior Subordinated Notes due 2014 (CUSIP No: 338032 AZ 8), and --6 1/8 percent...
HAMPTON, N.H. -- Fisher Scientific International Inc. (NYSE: FSH) will present at the Goldman Sachs Annual Global Healthcare Conference at the Ritz Carlton Laguna Niguel Hotel in Dana Point, Calif., on Wednesday, June 15 at 10:20 a.m. Pacific Time (1:20 p.m. Eastern). A live webcast of Fisher's presentation (slides and...
HAMPTON, N.H. -- Fisher Scientific International Inc. (NYSE: FSH) filed an S-3 Registration Statement with the Securities and Exchange Commission SEC today. The shelf registration allows the company to issue up to $1 billion of debt and equity securities. This registration statement replaces the existing shelf-registration statement that was filed...
PORTSMOUTH, N.H. -- Apogent Technologies Inc. (NYSE: AOT) announced today that it has received the requisite consents to execute a supplemental indenture amending the indenture relating to its $250 million principal amount of 6 1/2 percent senior subordinated notes due 2013 (CUSIP Nos. 03760AAF8 and 03760AAG6) (the "Notes") pursuant to...
HAMPTON & PORTSMOUTH, N.H. -- Fisher Scientific International Inc. (NYSE: FSH) and Apogent Technologies Inc. (NYSE: AOT) announced today that they are extending the expiration date for the exchange offer and consent solicitation relating to $345 million of Apogent's Floating Rate Senior Convertible Contingent Debt Securities due 2033 and the...
PORTSMOUTH, N.H. -- Apogent Board of Directors Unanimously Recommends Stockholders Vote for Proposed Merger Apogent Technologies Inc. (NYSE: AOT) announced today that it will reconvene its special stockholder meeting on Aug. 2 at 9 a.m. Central Daylight Time CDT for the purpose of holding a stockholder vote on the...
PORTSMOUTH, N.H. -- Apogent Technologies Inc. (NYSE: AOT) announced today that it has extended the expiration of the tender offer and consent solicitation period for any and all of its $250 million principal amount of 6 1/2 percent senior subordinated notes due 2013 (CUSIP Nos. 03760AAF8 and 03760AAG6) (the "Notes")...
HAMPTON, N.H. -- Fisher Board of Directors Unanimously Recommends Stockholders Vote for Proposed Merger Fisher Scientific International Inc. (NYSE: FSH) announced today that it will reconvene its annual meeting on Aug. 2 at 9 a.m. Eastern Daylight Time EDT for the purpose of holding a stockholder vote on the...
HAMPTON, N.H. & PORTSMOUTH, N.H. -- Fisher Scientific International Inc. (NYSE: FSH) and Apogent Technologies Inc. (NYSE: AOT) announced today that they are extending the expiration date for the exchange offer and consent solicitation relating to $345 million of Apogent's Floating Rate Senior Convertible Contingent Debt Securities due 2033 and...
PORTSMOUTH, N.H. -- Apogent Technologies Inc. (NYSE: AOT) announced today that it has extended the expiration of the tender offer and consent solicitation period for any and all of its $250 million principal amount of 6 1/2 percent senior subordinated notes due 2013 (CUSIP Nos. 03760AAF8 and 03760AAG6) (the "Notes")...
HAMPTON, N.H. -- Fisher Scientific International Inc. (NYSE: FSH) announced today that it has been informed by Apogent Technologies Inc. (NYSE: AOT) that based on a review by Apogent's Board of Directors and its Audit Committee, Apogent's Molecular BioProducts Inc. MBP subsidiary in San Diego, Calif., may have improperly recognized...
PORTSMOUTH, N.H. -- Apogent Technologies Inc. (NYSE: AOT) announced today that the vote on the pending merger with Fisher Scientific International Inc. (NYSE: FSH), presently scheduled for June 28, 2004, will be postponed. This is due to the recent determination by Apogent that its Molecular BioProducts Inc. MBP subsidiary in...
PORTSMOUTH, N.H. -- Apogent Technologies Inc. (NYSE: AOT) announced today that it has extended the consent solicitation period for any and all of its $250 million principal amount of 6 1/2 percent senior subordinated notes due 2013 (CUSIP Nos. 03760AAF8 and 03760AAG6) (the "Notes") from June 17, 2004, to 5...
Business Editors/Health/Medical Writers PORTSMOUTH, N.H.--BUSINESS WIRE--June 14, 2004 Apogent Technologies Inc. (NYSE: AOT) announced today that it has extended the consent solicitation period for any and all of its $250 million principal amount of 6 1/2 percent senior subordinated notes due 2013 (CUSIP Nos. 03760AAF8 and 03760AAG6) (the...
Business Editors HAMPTON & PORTSMOUTH, N.H.--BUSINESS WIRE--June 15, 2004 Fisher Scientific International Inc. (NYSE: FSH) and Apogent Technologies Inc. (NYSE: AOT) announced today that they have provided conversion-right notices to the holders of Apogent's Floating Rate Senior Convertible Contingent Debt Securities due 2033 (CUSIP No. 03760AAJ0) (the "Floating...
Business Editors HAMPTON and PORTSMOUTH, N.H.--BUSINESS WIRE--May 24, 2004 Fisher Scientific International Inc. (NYSE: FSH) and Apogent Technologies Inc. (NYSE: AOT) today filed two registration statements with the Securities and Exchange Commission for potential exchange offers that relate to an aggregate of $645 million of Apogent's existing debt...
Business Editors/Health/Medical Writers MULTIMEDIA AVAILABLE: http://www.businesswire.com/cgi-bin/mmg.cgi?eid=4646099 HAMPTON N.H. & PORTSMOUTH, N.H.--BUSINESS WIRE--May 21, 2004 Fisher Scientific International Inc. (NYSE: FSH) and Apogent Technologies Inc. (NYSE: AOT) today announced the expiration of the waiting period required under the Hart-Scott-Rodino Antitrust Improvements Act in connection with the previously...
Beat the crowds and save big on their favorite sports gear! Shop today
